Immunogenicity and safety of a SARS-CoV-2 inactivated vaccine (CoronaVac) co-administered with an inactivated quadrivalent influenza vaccine: A randomized, open-label, controlled study in healthy adults aged 18 to 59 years in China

BACKGROUND: Studies are needed for evidence of inactivated COVID-19 vaccine co-administered with influenza vaccine. METHODS: A randomized, open-label, controlled study was conducted in Zhejiang Province, China. Eligible healthy adults aged 18–59 years underwent randomization at a ratio of 1:1:2 to r...

Descripción completa

Detalles Bibliográficos
Autores principales: Shenyu, Wang, Xiaoqian, Duan, Bo, Chen, Xuan, Deng, Zeng, Wang, Hangjie, Zhang, Qianhui, Zheng, Zhenzhen, Liang, Chuanfu, Yan, Juan, Yang, Gang, Zeng, Huakun, Lv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343811/
https://www.ncbi.nlm.nih.gov/pubmed/35933275
http://dx.doi.org/10.1016/j.vaccine.2022.07.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343811/
https://www.ncbi.nlm.nih.gov/pubmed/35933275
http://dx.doi.org/10.1016/j.vaccine.2022.07.021

Ejemplares similares